Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Maze Therapeutics (NASDAQ:MAZE)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Maze Therapeutics Charts.

Maze Therapeutics (NASDAQ:MAZE)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Maze Therapeutics Charts.

Maze Therapeutics Inc News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 11 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 8 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
Saturday 8 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering
Friday 31 January 2025 (4 weeks ago) • GlobeNewswire Inc.

More Maze Therapeutics Inc News Articles

HSBC MSCI World Climate ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions